North America NAFLD Industry Analysis, Emerging Therapeutics & Market Projections to 2034
The Non-Alcoholic Fatty Liver Disease (NAFLD) Market is expanding rapidly as pharmaceutical developers, healthcare systems, diagnostic providers, and payers accelerate efforts to detect silent liver fibrosis early, halt progression to non-alcoholic steatohepatitis (NASH/MASH) and cirrhosis, and deploy targeted disease-modifying therapies. Growth is supported by escalating global obesity and...
0 Comentários 0 Compartilhamentos 14 Visualizações 0 Anterior
SocioMint https://sociomint.com